PR Newswire Clinical TrialsOriginal article
JACC: Clinical Electrophysiology veröffentlicht die 12-Monats-Ergebnisse der ersten Field PULSE-Studie am Menschen von Field Medical: 94,2 % PVI-Haltbarkeit pro Vene bei optimierter Wellenform
Data ReadoutpositiveFieldForce™-PFA-SystemPositive
AI Analysis
Summary
Field Medical announced 12-month results from its Field PULSE human study showing 94.2% PVI durability per vein with optimized waveform using the FieldForce PFA System. The data supports the company's instantaneous ablation workflow for high-voltage focal pulmonary vein ablation.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
12-month Field PULSE study results showing 94.2% PVI durability per vein with optimized waveform; HRX data demonstrating instantaneous ablation workflow
Importance:6/10
Sentiment:
0.75
electrophysiologyatrial fibrillationablationclinical datapulmonary vein isolationhigh-voltage focal PFA
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 20, 2026 7:37 PM